Delivery Order SPE2DB22D3301-SPE2DB25FZ0HH
Award Date 9/2/25
Potential Completion Date 9/23/25
Potential Value $26K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HEMLIBRA 105 MG/0.7 ML vials, with a ceiling value of $6,168.26 under a firm fixed-price contract. The award was made on September 2, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside delivery order represents a specific pharmaceutical procurement request fulfilled through the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,673.08 to AmerisourceBergen Drug Corp for the supply of HEMLIBRA 105 mg/0.7 ml vials. This is a firm fixed-price, non-set-aside contract with a completion date of August 8, 2025, and was awarded on July 18, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order operates under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $24,673.08 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Hemlibra 105 mg/0.7 ml vials. This is a firm fixed-price delivery order with a completion date of September 2, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competitively awarded. Hemlibra is a specialty pharmaceutical product used in the treatment of hemophilia,...
- The Defense Logistics Agency awarded a $17,634.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HEMLIBRA 150 mg/mL vials on August 25, 2025. This non-set-aside contract is scheduled for completion by September 16, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. HEMLIBRA is a specialized hemophilia A therapeutic product, reflecting the pharmaceutical distributor's role in supplying critical medications to support military and federal healthcare...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,564.08 firm fixed-price delivery order is for the supply of HEMLIBRA 150 MG/ML VIALML, a critical medical product, with a period of performance through January 22, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,336.54 firm fixed-price delivery order contract is for the supply of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a $24,673.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hemlibra 105 mg/0.7 ml vials, a specialty medication. There is no set-aside designation, indicating this was an open competition. The contract has an ultimate completion date of March 31, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain for Heparin 2,000 Unit/1,000 mL in Normal Saline, 1,000 mL units, valued at $1,012.44. This award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a competitively awarded, firm fixed-price contract with no set-aside designation. The delivery order was placed against AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $26,605.30 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Herceptin Hylecta 600mg injectable medication (10,000 5ml units). This firm fixed-price delivery order, which has no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. The award represents a competitive procurement through the company's existing...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $68.97 to Amerisourcebergen Drug Corp Corporate Office Division for HEPARIN SOD 5,000 UNIT/ML VIALML. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products from its place of performance in Conshohocken, Pennsylvania between August 4-7, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense, procuring...